KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Cash & Current Investments (2018 - 2025)

Adaptive Biotechnologies' Cash & Current Investments history spans 8 years, with the latest figure at $227.0 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 2.11% to $227.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $227.0 million, a 2.11% increase, with the full-year FY2025 number at $227.0 million, up 2.11% from a year prior.
  • Cash & Current Investments hit $227.0 million in Q4 2025 for Adaptive Biotechnologies, up from $212.8 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for ADPT hit a ceiling of $714.3 million in Q1 2021 and a floor of $193.4 million in Q1 2025.
  • Historically, Cash & Current Investments has averaged $365.4 million across 5 years, with a median of $358.3 million in 2021.
  • Biggest five-year swings in Cash & Current Investments: plummeted 50.3% in 2021 and later skyrocketed 41.11% in 2022.
  • Tracing ADPT's Cash & Current Investments over 5 years: stood at $353.1 million in 2021, then skyrocketed by 41.11% to $498.2 million in 2022, then plummeted by 30.47% to $346.4 million in 2023, then tumbled by 35.83% to $222.3 million in 2024, then rose by 2.11% to $227.0 million in 2025.
  • Business Quant data shows Cash & Current Investments for ADPT at $227.0 million in Q4 2025, $212.8 million in Q3 2025, and $197.9 million in Q2 2025.